You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Complement

Showing 1 - 25 of 3,526
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Preeclampsia, Severe Preeclampsia, Eculizumab Trial in Los Angeles (Eculizumab)

Suspended
  • Preeclampsia
  • +11 more
  • Los Angeles, California
    Cedars-Sinai Medical Center
Jun 16, 2022

Music Therapy Trial in Karlstad (Music)

Recruiting
  • Music Therapy
  • Music
  • Karlstad, Värmland, Sweden
    Department of Anesthesia & Intensive Care
Nov 9, 2022

Link Between Complement Activation and IgA Nephropathy Severity

Recruiting
  • IgA Nephropathy Severity in Kidney Transplantation
  • IgAN patients
  • Strasbourg, France
    Service de néphrologie
Aug 18, 2022

Identify Patients With Complement Factor I Deficiencies

Terminated
  • Previous Diagnosis With a Complement-mediated Disease and/or With Clinical Manifestations Reasonably Associated With Complement Factor I Deficiency
    • Huntsville, Alabama
      Nephrology Consultants, LLC
    Mar 31, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • Whittier, California
    • +8 more
    Nov 29, 2022

    C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

    Not yet recruiting
    • C3G
    • +11 more
    • (no location specified)
    Apr 13, 2023

    Complement Deficiencies Trial (CSL040, Placebo)

    Not yet recruiting
    • Complement Deficiencies
    • (no location specified)
    Jul 6, 2023

    Preeclampsia Trial (Preconditionning)

    Not yet recruiting
    • Preeclampsia
    • Preconditionning
    • (no location specified)
    Sep 29, 2022

    Complement C5a Receptors in Hidradenitis Suppurativa

    Recruiting
    • Hidradenitis Suppurativa
      • Redwood City, California
        Stanford University
      Jun 27, 2022

      Generalized Myasthenia Gravis Trial (zilucoplan (RA101495))

      Not yet recruiting
      • Generalized Myasthenia Gravis
      • zilucoplan (RA101495)
      • (no location specified)
      Aug 22, 2022

      Complement Abnormality, Peripheral Blood Mononuclear Cells, Covid19 Trial in Jette (Blood analysis)

      Recruiting
      • Complement Abnormality
      • +2 more
      • Blood analysis
      • Jette, Brussels, Belgium
        UZ Brussel
      Feb 25, 2022

      Hemolytic-Uremic Syndrome, Membranoproliferative Glomerulonephritis, Healthy Trial in Ranica (C3NEF assay)

      Not yet recruiting
      • Hemolytic-Uremic Syndrome
      • +2 more
      • C3NEF assay
      • Ranica, BG, Italy
        Centro di Ricerche Cliniche per le Malattie Rare "Aldo e Cele Da
      Aug 9, 2023

      Covid19, Thrombotic Microangiopathies, Acute Kidney Injury Trial in Boston (Ravulizumab)

      Active, not recruiting
      • Covid19
      • +2 more
      • Boston, Massachusetts
        Brigham and Women's Hospital
      Dec 31, 2022

      Assess Clinical Outcomes of Complement Factor I

      Terminated
      • Recurrent Bacterial Infection, Autoimmune Disorder
      • Natural History Observation
      • Huntsville, Alabama
        Nephrology Consultants, LLC
      Mar 31, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Jan 17, 2023

      Age-Related Macular Degeneration Trial in Vienna (the polymerase chain reaction (PCR))

      Recruiting
      • Age-Related Macular Degeneration
      • the polymerase chain reaction (PCR)
      • Vienna, Austria
        Department of Clinical Pharmacology, Medical University of Vienn
      Apr 6, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (Danicopan)

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Baltimore, Maryland
      • +4 more
      Feb 1, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Iptacopan (LNP023))

      Active, not recruiting
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Iptacopan (LNP023)
      • Tianjin, Tianjin, China
      • +11 more
      Nov 21, 2022

      Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

      Not yet recruiting
      • Neuromyelitis Optica Spectrum Disorder
      • +2 more
        • (no location specified)
        Jul 21, 2023

        Paroxysmal Nocturnal Hemoglobinuria Trial in China (Crovalimab)

        Active, not recruiting
        • Paroxysmal Nocturnal Hemoglobinuria
        • Changchun City, China
        • +5 more
        Jul 11, 2022

        C3 Glomerulopathy (C3G) Trial (Iptacopan)

        Available
        • C3 Glomerulopathy (C3G)
        • (no location specified)
        Jan 24, 2023

        Weight Management, Food Complement Trial in Lille (Placebo supplement, Naticol supplement)

        Completed
        • Weight Management
        • Food Complement
        • Placebo supplement
        • Naticol supplement
        • Lille, Nord, France
          NutrInvest - Institut Pasteur de Lille
        Dec 6, 2022

        Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (BCX9930 monotherapy, Placebo)

        Active, not recruiting
        • Paroxysmal Nocturnal Hemoglobinuria (PNH)
        • BCX9930 monotherapy
        • Placebo
        • Ampang, Malaysia
        • +3 more
        Dec 15, 2022

        Cardiopulmonary Bypass, Inflammatory Response, Platelet Dysfunction Trial in Innsbruck

        Recruiting
        • Cardiopulmonary Bypass
        • +2 more
          • Innsbruck, Tyrol, Austria
            University Hospital Innsbruck
          Aug 30, 2021

          New Complement Components in Childhood Lupus Nephritis

          Not yet recruiting
          • Lupus Nephritis
          • C4d evaluation in lupus nephritis in serum and renal tissue
          • (no location specified)
          Oct 7, 2021